feed,title,long_url,short_url
MedRxiv,Risk of Adverse Events Following Monovalent Third or Booster Dose of COVID-19 mRNA Vaccination in U.S. Adults Ages 18 Years and Older,https://medrxiv.org/cgi/content/short/2024.02.20.24303089v1?rss=1,https://da.gd/5Sr1G5
